Introduction: Somatostatin and dopamine receptors are both G-protein-coupled receptors.
Somatostatin receptor (SSTR) expression in neuroendocrine tumours has been well …

Somatostatin (SS) and dopamine (DA) receptors have been highlighted as two critical
regulators in the negative control of hormonal secretion in a wide group of human endocrine …

Context The expression of somatostatin (sstr1‐5) and dopamine (DR) receptors in
neuroendocrine neoplasms (NEN s) facilitates diagnosis by tumour visualization with …

Objectives: To evaluate somatostatin receptor 2A (SSTR2A) and dopamine receptor 2 (DR2)
protein expression in somatotropinomas and to relate it to response to somatostatin …

The role of somatostatin and dopamine receptors as molecular targets for the treatment of
patients with pituitary adenomas is well established. Indeed, dopamine and somatostatin …

Somatostatin and its synthetic analogs act through five specific somatostatin receptors (sstr1–
5), found on the cell membrane of various tumors, including endocrine ones. Dopamine—a …

Objective Somatostatin (sst) are present in the majority of gastro-entero-pancreatic (GEP)
tumours. Effects of somatostatin receptor (sst) analogues are partial and of limited duration …

Well-differentiated neuroendocrine tumors (NT) expresses somatostatin receptors (sstr). A
composition of sstr subtype determines biological behavior. We therefore evaluated their …

A combination of basic research observations concerning the interaction of somatostatin
(SST) and dopamine (DA) receptors, and clinical reports of enhanced efficacy of combined …

Objective: The expression of somatostatin receptors (SSTRs) and dopamine receptor 2
(DR2) in neuroendocrine tumors is of clinical importance as somatostatin analogues and …